Clinical Research Services

SGS can significantly improve client’s drug development timelines and decision-making processes with innovative study designs, optimal facilities, and strong regulatory intelligence.

Our state of the art facilities include: Phase I units with a total of 162 beds, bioanalytical labs, and Phase II-IV clinical trial management offices across Europe, North America and Asia

Taking a drug candidate from preclinical studies through an entire clinical drug development program requires an enormous commitment of resources and bears a number challenges.

SGS’ Life Science Services has 30 years of experience as a global CRO, providing integrated solutions from preclinical activities to Phase I-IV trials, bioanalytical and QC testing. SGS serves the pharmaceutical, biotechnology and medical device industries with over 1, 300 employees and 2, 000 trials performed.

• Bioanalysis Services
• Early Phase Services
• Late Phase Services